Freeline Therapeutics Holdings
Stock Forecast, Prediction & Price Target
Freeline Therapeutics Holdings Financial Estimates
Freeline Therapeutics Holdings Revenue Estimates
Freeline Therapeutics Holdings EBITDA Estimates
Freeline Therapeutics Holdings Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2020 | 12/31/2021 | 12/31/2022 | 12/31/2025 | |||
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $44.55M Low: $74.82M High: $23.20M avg. 0% | |||
Net Income
% change YoY
| $-96.32M N/A | $-140.39M -45.75% | $-88.97M 36.62% | Avg: $-27.54M Low: $-1.77M High: $11.85M avg. 69.03% | |||
EBITDA
% change YoY
| $-85.26M N/A | $-133.13M -56.14% | $-97.17M 27.01% | Avg: $0 Low: $0 High: $0 avg. 100% | |||
EPS
% change YoY
| -$102.09 N/A | -$58.98 42.22% | -$22.52 61.81% | Avg: $0.09 Low: -$0.03 High: $0.2 avg. 100.37% | |||
Operating Expenses
% change YoY
| $87.18M N/A | $137.90M 58.18% | $95.28M -30.90% | Avg: $0 Low: $0 High: $0 avg. -100% | |||
FAQ
What is Freeline Therapeutics Holdings stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 69.03% in 2025-2025.
We have gathered data from 2 analysts. Their low estimate is -1.77M, average is -27.54M and high is 11.85M.
What is Freeline Therapeutics Holdings stock revenue growth forecast?
We have gathered data from 2 analysts. Their low revenue estimate is $74.82M, average is $44.55M and high is $23.20M.
What is Freeline Therapeutics Holdings stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 100.37% in 2025-2025.
We have gathered data from 2 analysts. Their low earnings per share estimate is -$0.03, average is $0.09 and high is $0.2.
What is the best performing analyst?
In the last twelve months analysts have been covering Freeline Therapeutics Holdings stock. The most successful analyst is Dae Gon Ha.